Kane CM, Hoskin P, Bennett MI (2015) Cancer induced bone pain. BMJ 350:h315. https://doi.org/10.1136/bmj.h315
Colosia A, Njue A, Bajwa Z, Dragon E, Robinson RL, Sheffield KM, Thakkar S, Richiemer SH (2022) The burden of metastatic cancer-induced bone pain: a narrative review. J Pain Res 15:3399–3412. https://doi.org/10.2147/JPR.S371337
Article PubMed PubMed Central Google Scholar
Middlemiss T, Laird BJ, Fallon MT (2011) Mechanisms of cancer-induced bone pain. Clin Oncol (Royal College of Radiologists (Great Britain)) 23(6):387–392. https://doi.org/10.1016/j.clon.2011.03.003
van der Velden JM, van der Linden YM, Versteeg AL, Verlaan JJ, Sophie Gerlich A, Pielkenrood BJ, Kasperts N, Verkooijen HM (2018) Evaluation of effectiveness of palliative radiotherapy for bone metastases: a prospective cohort study. J Radiat Oncol 7(4):325–333. https://doi.org/10.1007/s13566-018-0363-6
Article CAS PubMed PubMed Central Google Scholar
Paice JA, Bohlke K, Barton D, Craig DS, El-Jawahri A, Hershman DL, Kong LR, Kurita GP, LeBlanc TW, Mercadante S, Novick KLM, Sedhom R, Seigel C, Stimmel J, Bruera E (2023) Use of opioids for adults with pain from cancer or cancer treatment: ASCO guideline. J Clin Oncol 41(4):914–930. https://doi.org/10.1200/JCO.22.02198
Body JJ, von Moos R, Rider A, Hallworth P, Bhowmik D, Gatta F, Hechmati G, Qian Y (2019) A real-world study assessing the use of bone-targeted agents and their impact on bone metastases in patients with prostate cancer treated in clinical practice in Europe. J Bone Oncol 14:100212. https://doi.org/10.1016/j.jbo.2018.100212
Kirou-Mauro AM, Hird A, Wong J, Sinclair E, Barnes EA, Tsao M, Danjoux C, Chow E (2009) Has pain management in cancer patients with bone metastases improved? A seven-year review at an outpatient palliative radiotherapy clinic. J Pain Symptom Manage 37(1):77–84. https://doi.org/10.1016/j.jpainsymman.2007.12.014
Vieira C, Fragoso M, Pereira D, Medeiros R (2019) Pain prevalence and treatment in patients with metastatic bone disease. Oncol Lett 17(3):3362–3370. https://doi.org/10.3892/ol.2019.10013
Article CAS PubMed PubMed Central Google Scholar
Laird BJ, Walley J, Murray GD, Clausen E, Colvin LA, Fallon MT (2011) Characterization of cancer-induced bone pain: an exploratory study. Support Care Cancer 19(9):1393–1401. https://doi.org/10.1007/s00520-010-0961-3
Deandrea S, Corli O, Consonni D, Villani W, Greco MT, Apolone G (2014) Prevalence of breakthrough cancer pain: a systematic review and a pooled analysis of published literature. J Pain Symptom Manage 47(1):57–76. https://doi.org/10.1016/j.jpainsymman.2013.02.015
van den Beuken-van Everdingen MH, Hochstenbach LM, Joosten EA, Tjan-Heijnen VC, Janssen DJ (2016) Update on prevalence of pain in patients with cancer systematic review and meta-analysis. J Pain Symptom Manage 51(6):1070-1090 e1079. https://doi.org/10.1016/j.jpainsymman.2015.12.340
Zajaczkowska R, Kocot-Kepska M, Leppert W, Wordliczek J (2019) Bone pain in cancer patients: mechanisms and current treatment. Int J Mol Sci 20 (23). https://doi.org/10.3390/ijms20236047
Fallon M, Hoskin PJ, Colvin LA, Fleetwood-Walker SM, Adamson D, Byrne A, Murray GD, Laird BJ (2016) Randomized double-blind trial of pregabalin versus placebo in conjunction with palliative radiotherapy for cancer-induced bone pain. J Clin Oncol 34(6):550–556. https://doi.org/10.1200/JCO.2015.63.8221
Article CAS PubMed Google Scholar
Afsharimani B, Kindl K, Good P, Hardy J (2015) Pharmacological options for the management of refractory cancer pain-what is the evidence? Support Care Cancer 23(5):1473–1481. https://doi.org/10.1007/s00520-015-2678-9
Article CAS PubMed Google Scholar
Ding H, Song Y, Xin W, Sun J, Zhong L, Zhou Q, He C, Gong L, Fang L (2022) Methadone switching for refractory cancer pain. BMC Palliat Care 21(1):191. https://doi.org/10.1186/s12904-022-01076-2
Article PubMed PubMed Central Google Scholar
McPherson ML, Walker KA, Davis MP, Bruera E, Reddy A, Paice J, Malotte K, Lockman DK, Wellman C, Salpeter S, Bemben NM, Ray JB, Lapointe BJ, Chou R (2019) Safe and appropriate use of methadone in hospice and palliative care: expert consensus white paper. J Pain Symptom Manage 57(3):635-645 e634. https://doi.org/10.1016/j.jpainsymman.2018.12.001
Sulistio M, Wojnar R, Key S, Kwok J, Al-Rubaie Z, Michael N (2021) The role of methadone in cancer-induced bone pain: a retrospective cohort study. Support Care Cancer 29(3):1327–1335. https://doi.org/10.1007/s00520-020-05606-7
Michael N, Sulistio M, Wojnar R, Gorelik A (2023) Methadone rotation versus other opioid rotation for refractory cancer induced bone pain: protocol of an exploratory randomised controlled open-label study. BMC Palliat Care 22(1):42. https://doi.org/10.1186/s12904-023-01160-1
Article PubMed PubMed Central Google Scholar
Paice JA, Mulvey M, Bennett M, Dougherty PM, Farrar JT, Mantyh PW, Miaskowski C, Schmidt B, Smith TJ (2017) AAPT diagnostic criteria for chronic cancer pain conditions. J Pain: Off J Am Pain Soc 18(3):233–246. https://doi.org/10.1016/j.jpain.2016.10.020
Fallon M, Giusti R, Aielli F, Hoskin P, Rolke R, Sharma M, Ripamonti CI, Committee EG (2018) Management of cancer pain in adult patients: ESMO Clinical Practice Guidelines. Ann Oncol 29(Suppl 4):iv166–iv191. https://doi.org/10.1093/annonc/mdy152
Article CAS PubMed Google Scholar
Thong ISK, Jensen MP, Miro J, Tan G (2018) The validity of pain intensity measures: what do the NRS, VAS, VRS, and FPS-R measure? Scand J Pain 18(1):99–107. https://doi.org/10.1515/sjpain-2018-0012
Basch E, Becker C, Rogak LJ, Schrag D, Reeve BB, Spears P, Smith ML, Gounder MM, Mahoney MR, Schwartz GK, Bennett AV, Mendoza TR, Cleeland CS, Sloan JA, Bruner DW, Schwab G, Atkinson TM, Thanarajasingam G, Bertagnolli MM, Dueck AC (2021) Composite grading algorithm for the National Cancer Institute’s Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE). Clin Trials 18(1):104–114. https://doi.org/10.1177/1740774520975120
McLean S, Twomey F (2015) Methods of rotation from another strong opioid to methadone for the management of cancer pain: a systematic review of the available evidence. J Pain Symptom Manage 50(2):248-259 e241. https://doi.org/10.1016/j.jpainsymman.2015.02.029
Caraceni A, Hanks G, Kaasa S, Bennett MI, Brunelli C, Cherny N, Dale O, De Conno F, Fallon M, Hanna M, Haugen DF, Juhl G, King S, Klepstad P, Laugsand EA, Maltoni M, Mercadante S, Nabal M, Pigni A, Radbruch L, Reid C, Sjogren P, Stone PC, Tassinari D, Zeppetella G, European Palliative Care Research C, European Association for Palliative C (2012) Use of opioid analgesics in the treatment of cancer pain: evidence-based recommendations from the EAPC. Lancet Oncol 13 (2):e58-68. https://doi.org/10.1016/S1470-2045(12)70040-2
Mercadante S, Caraceni A (2011) Conversion ratios for opioid switching in the treatment of cancer pain: a systematic review. Palliat Med 25(5):504–515. https://doi.org/10.1177/0269216311406577
Fine PG, Portenoy RK (2009) Ad hoc expert panel on evidence review and guidelines for opioid rotation. Establishing “best practices” for opioid rotation: conclusions of an expert panel. J Pain Symptom Manage. 38(3):418–25. https://doi.org/10.1016/j.jpainsymman.2009.06.002
Article PubMed PubMed Central Google Scholar
Ayonrinde OT, Bridge DT (2000) The rediscovery of methadone for cancer pain management. Med J Aust 173(10):536–540
Article CAS PubMed Google Scholar
Leppert W (2009) The role of methadone in cancer pain treatment–a review. Int J Clin Pract 63(7):1095–1109. https://doi.org/10.1111/j.1742-1241.2008.01990.x
Article CAS PubMed Google Scholar
Soares LG (2005) Methadone for cancer pain: what have we learned from clinical studies? Am J Hosp Palliat Care 22(3):223–227. https://doi.org/10.1177/104990910502200312
Oriani A, Fusi-Schmidhauser T, Guo P (2021) Should end-of-life patients be enrolled as participants in clinical research? A best-fit framework synthesis. J Adv Nurs 77(4):1656–1666. https://doi.org/10.1111/jan.14712
Comments (0)